Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.91 USD | -4.84% | -22.80% | -44.52% |
10/05 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
07/05 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.52% | 4.6M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Palisade Bio : to Sell Neurogenic Compound Previously Part of Seneca Biopharma's Product Range